Changeflow GovPing Pharma & Drug Safety DEA Addresses Drug Threats, Pharmacy Crime at D...
Routine Notice Added Final

DEA Addresses Drug Threats, Pharmacy Crime at Diversion Summit

Favicon for www.dea.gov DEA Press Releases
Published
Detected
Email

Summary

DEA Assistant Administrator Cheri Oz addressed emerging drug threats, pharmacy crime, and prescription drug misuse at the National Association of Drug Diversion Investigators Rx Diversion Summit in Covington, KY. The remarks targeted over 300 pharmacists, investigators, and hospital leaders on controlled substance enforcement priorities.

Published by DEA on x.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

DEA Assistant Administrator Cheri Oz delivered remarks at the National Association of Drug Diversion Investigators Rx Diversion Summit addressing emerging drug threats, pharmacy crime, and prescription drug misuse to an audience of over 300 pharmacists, investigators, and hospital leaders. The summit serves as a forum for drug diversion investigators and healthcare professionals to discuss controlled substance enforcement.

Healthcare providers including pharmacists and hospital administrators should monitor DEA communications for emerging enforcement priorities and guidance on diversion prevention. The summit highlights ongoing DEA engagement with healthcare stakeholders on controlled substance issues.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Post

DEA HQ @DEAHQ DEA Asst. Admin. Cheri Oz addresses emerging drug threats, pharmacy crime, & Rx misuse to more than 300 pharmacists, investigators, and hospital leaders at the Natl. Assoc. of Drug Diversion Investigators Rx Diversion Summit in Covington, KY. #DEADIVERSION ALT
7:30 pm · 15 Apr 2026
934 Views 4 8 9


New to X?

Sign up now to get your own personalized timeline! Sign up with Google Sign up with Apple Create account By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Relevant people

What’s happening

Trending in United Kingdom RIP Alex Trending in United Kingdom Street Fighter Trending in United Kingdom #fairdealforwednesday Trending with Chansiri Trending in United Kingdom Alex Manninger Show more

Get daily alerts for DEA Press Releases

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from DEA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
DEA
Published
April 15th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Law enforcement Pharmaceutical companies
Industry sector
6211 Healthcare Providers
Activity scope
Drug diversion prevention Pharmacy regulation Controlled substance enforcement
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Topics
Healthcare Criminal Justice

Get alerts for this source

We'll email you when DEA Press Releases publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!